Back
Editas Medicine Vs. Avidity Biosciences Industry Stock Comparison
Sell
49
EDIT
Editas Medicine
Last Price:
$2.28
Seasonality Move:
-2.7%
Sell
23
RNA
Avidity Biosciences
Last Price:
$29.02
Seasonality Move:
-5.8%
Sell
49
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
-
The current Editas Medicine [EDIT] share price is $2.28. The Score for EDIT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $29.03. The Score for RNA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $2.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight buying pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $29.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 60.89 | Buy |
Chaikin Money Flow: | 2731493 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.76 - 2.2) | Buy |
Bollinger Bands (100): | (1.22 - 1.96) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 41.42 | Sell |
Chaikin Money Flow: | -1132722 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.41 - 33.49) | Sell |
Bollinger Bands (100): | (28.02 - 33.1) | Sell |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.21 | Buy |
20-day SMA: | 2.04 | Buy |
50-day SMA: | 1.73 | Buy |
200-day SMA: | 2.05 | Buy |
8-day EMA: | 2.18 | Buy |
20-day EMA: | 2.05 | Buy |
50-day EMA: | 1.72 | Buy |
200-day EMA: | 0.82 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.47 | Sell |
20-day SMA: | 31.6 | Sell |
50-day SMA: | 30.61 | Sell |
200-day SMA: | 35.12 | Sell |
8-day EMA: | 29.83 | Sell |
20-day EMA: | 30.58 | Sell |
50-day EMA: | 30.68 | Sell |
200-day EMA: | 32.08 | Sell |
Editas Medicine Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.07 per share, an increase this year of $0.77 per share, and an increase next year of $0.78 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.15 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.46 per share.
Editas Medicine Technical Analysis
Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |